Immediate Impact

59 standout
Sub-graph 1 of 22

Citing Papers

A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
2025 Standout
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
2024 Standout
1 intermediate paper

Works of Eleni Vagdatli being referenced

Early initiation of the respiratory syncytial virus season in 2021–2022, Greece
2022

Author Peers

Author Last Decade Papers Cites
Eleni Vagdatli 42 49 22 207 92 30 527
Kağan Huysal 1 41 7 158 105 34 544
N. Paleiron 57 28 133 78 46 614
Luis A. Álvarez‐Sala‐Walther 34 7 150 42 15 529
C. B. Campbell 39 10 97 107 31 499
Jon D. Herrington 2 67 25 137 31 41 602
Gerald Hackl 1 78 13 172 125 44 573
Yukio Suga 3 43 31 74 75 57 475
Jan Fertmann 1 23 7 53 147 26 526
Amit Rout 130 9 107 83 54 627
Humberto Sifuentes 1 76 14 60 136 37 603

All Works

Loading papers...

Rankless by CCL
2026